Draximage Gluceptate imaging agent shortage expected to Nov 30
Jubilant DraxImage reports its Draximage Gluceptate kit (calcium glucoheptonate / stannous chloride, 25 mg / 3 mg powder for intravenous solution, DIN 02342006) faces an anticipated Tier 3 critical shortage from a manufacturing disruption. The shortage is anticipated from Aug 15, 2026 and expected to run until Nov 30, 2026.
Gluceptate is used in nuclear medicine kidney imaging — imaging departments should plan around the anticipated gap.
Shortage expected to end: Nov 30, 2026 All deadlines
Read the original
Official source: Draximage Gluceptate imaging agent shortage expected to Nov 30 (opens in a new tab) — Health Product Shortages Canada
